Research confirms trusted sources key to vaccination program success

Last month was World Immunization Week and never has it been a more pertinent milestone. It has been 13 months since the...

May 24, 2021 | Monday | Opinion
Singapore extends use of Pfizer-BioNTech COVID-19 vaccine to adolescents

The Health Sciences Authority (HSA) at Singapore has extended the authorisation of Pfizer-BioNTech COVID-19 vaccine for ...

May 19, 2021 | Wednesday | News
Australia to soon roll-out single-dose COVID-19 vaccine

A single-dose vaccine that targets new COVID-19 variants has been awarded funding to fast-track testing in human trials....

May 17, 2021 | Monday | News
Moderna to supply 25 M vaccine doses to Australia

Moderna, Inc., has announced a new supply agreement with the government of Australia for 25 million doses. Thi...

May 14, 2021 | Friday | News
Fosun, BioNTech invest $200 M to manufacture COVID-19 vaccine in China

Shanghai Fosun Pharma has signed a Joint Venture with BioNTech to manufacture mRNA vaccine in China. The JV will ha...

May 12, 2021 | Wednesday | News
EU inks the third contract with BioNTech/Pfizer securing 1.8 billion doses

The European Commission has approved a contract for 1.8 billion doses of the BioNTech/Pfizer vaccine. The contract cove...

May 11, 2021 | Tuesday | News
US approves Pfizer-BioNTech COVID-19 Vaccine for adolescents

The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech C...

May 11, 2021 | Tuesday | News
Australia's CSIRO suggests nasal delivery of Oxford-AZ vaccine to improve efficacy

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...

May 11, 2021 | Tuesday | News
China focuses on next-generation intranasal COVID-19 vaccines

COVID-19 infections continue to rise with several countries facing second-and third-wave infections with the newly evolv...

May 10, 2021 | Monday | News
WHO lists China's Sinopharm COVID-19 vaccine for emergency use

The World Health Organisation (WHO) has listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light ...

May 10, 2021 | Monday | News
Oxford’s malaria vaccine shows significant 75% efficacy in early trial

A malaria vaccine created by scientists at the University of Oxford’s Jenner Institute has been found to be 77% ef...

May 4, 2021 | Tuesday | News
WHO issues emergency use listing to Moderna COVID-19 vaccine

Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...

May 1, 2021 | Saturday | News
UK to host global fund-raising summit with CEPI to accelerate vaccine development

Plans to speed up vaccine development to prevent future pandemics and save lives will be boosted by a UK-hosted summit t...

May 3, 2021 | Monday | News
Thailand accelerates production of AstraZeneca COVID-19 vaccine

Thailand's Food and Drug Administration (FDA) has approved Siam Bioscience as a manufacturing facility for COV...

April 30, 2021 | Friday | News
Zuellig Pharma partners with Moderna to supply COVID-19 vaccine in Asia

Zuellig Pharma, a Singapore based healthcare services provider in Asia, and Moderna, Inc., a US based biotechnology...

April 29, 2021 | Thursday | News
RNAimmune accelerates R&D into mRNA vaccine, drug discovery

RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and va...

April 23, 2021 | Friday | News
Australia announces $50 M investment in mRNA vaccine manufacturing

The Victorian Government’s $50 million investment in mRNA vaccine manufacturing is welcome recognition of the worl...

April 21, 2021 | Wednesday | News
Moderna announces new supply agreement with Israel for 2022

Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...

April 22, 2021 | Thursday | News